Immediate Impact

1 by Nobel laureates 6 from Science/Nature 58 standout
Sub-graph 1 of 19

Citing Papers

Multiple myeloma
2024 Standout
The two sides of chromosomal instability: drivers and brakes in cancer
2024 Standout
25 intermediate papers

Works of Felipe de Arriba being referenced

Filanesib in combination with pomalidomide and dexamethasone in refractory MM patients: safety and efficacy, and association with alpha 1‐acid glycoprotein (AAG) levels. Phase Ib/II Pomdefil clinical trial conducted by the Spanish MM group
2020
Lenalidomide plus dexamethasone versus observation in patients with high-risk smouldering multiple myeloma (QuiRedex): long-term follow-up of a randomised, controlled, phase 3 trial
2016
and 12 more

Author Peers

Author Last Decade Papers Cites
Felipe de Arriba 1544 769 1053 69 1.8k
K.R. Desikan 1604 778 985 30 1.9k
Tommaso Caravita 1725 1074 1418 67 2.0k
Vittorio Montefusco 1248 640 797 88 1.6k
Lene Meldgaard Knudsen 1130 777 975 50 1.9k
Noemi Horvath 1158 957 963 60 1.7k
Matthew Jenner 1317 743 1243 85 1.8k
Inger Marie S. Dahl 1054 425 686 37 1.6k
Neha Korde 1396 751 1040 119 2.0k
Margareth C. Ozelo 1484 524 996 119 2.7k
Benjamin Van Camp 1111 683 762 59 1.8k

All Works

Loading papers...

Rankless by CCL
2026